Feng Y, Liu G, Li H, Cheng L
Sci China Life Sci. 2025; .
PMID: 40035969
DOI: 10.1007/s11427-024-2751-6.
Lim E, Kompocholi S, Brannvoll A, Bagge K, Gruhn J, Martin-Gonzalez J
Heliyon. 2025; 11(2):e41979.
PMID: 39897830
PMC: 11787654.
DOI: 10.1016/j.heliyon.2025.e41979.
Coquel F, Ho S, Tsai K, Yang C, Aze A, Devin J
Elife. 2025; 13.
PMID: 39887032
PMC: 11785374.
DOI: 10.7554/eLife.104718.
Liu Q, Li X, Xu H, Luo Y, Cheng L, Liang J
Adv Biotechnol (Singap). 2025; 3(1):2.
PMID: 39883359
PMC: 11740860.
DOI: 10.1007/s44307-024-00053-5.
Yoshimoto M, Washiyama K, Ohnuki K, Doi A, Inokuchi M, Kojima M
Pharmaceutics. 2025; 17(1).
PMID: 39861661
PMC: 11768328.
DOI: 10.3390/pharmaceutics17010009.
Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2- breast cancer.
Zhang H, Yang F, Xu Y, Zhao S, Jiang Y, Shao Z
Cell Rep Med. 2025; 6(2):101924.
PMID: 39848244
PMC: 11866502.
DOI: 10.1016/j.xcrm.2024.101924.
Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers.
Zhong Y, Wang R, Huang Z, Hu Z, Peng B, Chen B
Immun Inflamm Dis. 2025; 13(1):e70126.
PMID: 39817582
PMC: 11736640.
DOI: 10.1002/iid3.70126.
Tumorigenesis Caused by Aberrant Expression of GANP, a Central Component in the Mammalian TREX-2 Complex-Lessons from Transcription-Coupled DNA Damages.
Rezano A, Gondo N, Sakai Y, Nakamura Y, Phimsen S, Tani T
Int J Mol Sci. 2025; 25(24.
PMID: 39769375
PMC: 11727803.
DOI: 10.3390/ijms252413612.
Bayesian Phylogenetic Lineage Reconstruction with Loss of Heterozygosity Mutations Derived from Single-Cell RNA Sequencing.
Anderson D, Horwitz M
Methods Mol Biol. 2025; 2886:1-22.
PMID: 39745633
DOI: 10.1007/978-1-0716-4310-5_1.
Transcriptional analysis reveals the suppression of RAD51 and disruption of the homologous recombination pathway during PEDV infection in IPEC-J2 cells.
Sun L, Cao C, Yang J, Jin J
Virol J. 2024; 21(1):337.
PMID: 39731192
PMC: 11681661.
DOI: 10.1186/s12985-024-02611-8.
Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer.
Tsilingiri K, Chalari A, Christopoulou G, Voutsina A, Constantoulakis P, Potaris K
NPJ Precis Oncol. 2024; 8(1):291.
PMID: 39725687
PMC: 11671589.
DOI: 10.1038/s41698-024-00777-6.
Somatic Recombination Between an Ancient and a Recent Gene Variant Is Associated with the NOTCH2 Gain-of-Function Phenotype in Chronic Lymphocytic Leukemia.
Hubmann R, Hilgarth M, Lowenstern T, Lienhard A, Sima F, Reisinger M
Int J Mol Sci. 2024; 25(23).
PMID: 39684291
PMC: 11641350.
DOI: 10.3390/ijms252312581.
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.
Panagopoulou M, Panou T, Gkountakos A, Tarapatzi G, Karaglani M, Tsamardinos I
Clin Epigenetics. 2024; 16(1):178.
PMID: 39643918
PMC: 11622545.
DOI: 10.1186/s13148-024-01787-8.
RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.
Talens F, Teixeira V, Kok Y, Chen M, Rosenberg E, Debipersad R
NAR Cancer. 2024; 6(4):zcae044.
PMID: 39611179
PMC: 11604054.
DOI: 10.1093/narcan/zcae044.
SRY+ Derivative X Chromosome in a Female With Apparently Typical Sexual Development.
Brewer C, Coyan A, Smith N, Jones B, Smolarek T, Liu J
Mol Genet Genomic Med. 2024; 12(11):e70033.
PMID: 39530251
PMC: 11555487.
DOI: 10.1002/mgg3.70033.
Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors.
Kovina A, Luzhin A, Tatarskiy V, Deriglazov D, Petrova N, Petrova N
Int J Mol Sci. 2024; 25(21).
PMID: 39519361
PMC: 11546466.
DOI: 10.3390/ijms252111810.
DNA damage caused by chemotherapy has duality, and traditional Chinese medicine may be a better choice to reduce its toxicity.
Bai B, Ma Y, Liu D, Zhang Y, Zhang W, Shi R
Front Pharmacol. 2024; 15:1483160.
PMID: 39502534
PMC: 11534686.
DOI: 10.3389/fphar.2024.1483160.
DNA damage response in breast cancer and its significant role in guiding novel precise therapies.
Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H
Biomark Res. 2024; 12(1):111.
PMID: 39334297
PMC: 11437670.
DOI: 10.1186/s40364-024-00653-2.
Molecular mechanism of PARP inhibitor resistance.
Huang Y, Chen S, Yao N, Lin S, Zhang J, Xu C
Oncoscience. 2024; 11:69-91.
PMID: 39318358
PMC: 11420906.
DOI: 10.18632/oncoscience.610.
A marker-free genetic manipulation method for Glaesserella parasuis strains developed by alternately culturing transformants at 37°C and 30°C.
Xiao J, Wang Y, Wu D, Song Y, Cai X, Chen H
BMC Biotechnol. 2024; 24(1):60.
PMID: 39227838
PMC: 11373133.
DOI: 10.1186/s12896-024-00887-w.